Info

ZLB Behring is a global leader in the plasma protein biotherapeutics industry, dedicated to treating rare and serious diseases and improving the quality of life of patients throughout the world. Our comprehensive line of therapies include plasma-derived and recombinant products for the treatment of hemophilia and other coagulation disorders, immunoglobulins for the prevention and treatment of immune disorders, treatments that inhibit the formation of blood clots, wound-healing agents used during major surgical procedures and plasma expanders for the treatment of a variety of conditions such as shock, burns and circulatory disorders. Our products are produced at facilities in Bern, Switzerland; Marburg, Germany; and Kankakee, Illinois, in accordance with international safety and quality standards. Additionally, ZLB Behring operates one of the world's largest plasma collection networks. We are passionate about safety, quality and the customers we serve. Our extensive research and development and range of support services demonstrate our ongoing commitment to all who count on our products. ZLB Behring is a subsidiary of CSL a specialty biopharmaceutical company which operates worldwide from headquarters in Melbourne, Australia.